New Biomarker Assays for Early Alzheimer's are Approved by the FDA.

Published Date: 01 Jul 2023

The Elecsys beta-amyloid (1-42) and total-tau CSF assays (used as a tTau/Abeta42 ratio) are for use in adults 55 and older being evaluated for cognitive issues.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Relationship-building key to addressing oncologist shortages in rural care

2.

New protein target discovered for childhood medulloblastomas

3.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

4.

Papillary thyroid cancer: New markers offer hope for tailored treatment

5.

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot